🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the tolerability of BIA 9-1067 after...
Status
Completed
Location
BIOTRIAL
Start Date
2008-04
Trial ID
NCT02071810
Treatments Being Tested
The purpose of this study is to determine the effects of age on the pharmac...
Status
Completed
Location
BIOTRIAL
Start Date
2008-10
Trial ID
NCT02092168
Treatments Being Tested
The purpose of this study is to investigate the tolerability and the effect...
Status
Completed
Location
Department of Neurology C.M.D.T.A. NEOMED
Start Date
2010-02
Trial ID
NCT01568047
Treatments Being Tested
To investigate the effect of BIA 9-1067 in steady-state conditions on the l...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2009-03
Trial ID
NCT01533116
Treatments Being Tested
To investigate the effect of repeated dosing of BIA 9-1067 on the levodopa ...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2009-11
Trial ID
NCT01519284
Treatments Being Tested
The purpose of this study is to determine the effect of repeated dosing of ...
Status
Completed
Location
SGS aster
Start Date
2011-09
Trial ID
NCT02170376
Treatments Being Tested
This study aims to demonstrate the efficacy and safety of BIA 9-1067, compa...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2011-03
Trial ID
NCT01568073
Treatments Being Tested
To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2011-05
Trial ID
NCT01520987
Treatments Being Tested
The purpose of this study is to determine the effect of BIA 9 1067 (5 mg, 1...
Status
Completed
Location
BIOTRIAL
Start Date
2010-02
Trial ID
NCT02169414
Single-centre, open-label, fixed-sequence design consisting of 2 periods se...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02305030
Treatments Being Tested